Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Senores Pharmaceuticals Limited, is an unlisted public company incorporated on 26 December, 2017. It is classified as a public limited company and is located in Ahmedabad, Gujarat. It's authorized share capital is INR 59.00 cr and the total paid-up capital is INR 33.27 cr.
Senores Pharmaceuticals Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 253.88% over the previous year. At the same time, it's book networth has increased by 13.37%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Sanjay Shaileshbhai Majmudar | 00091305 | 1 years |
Director | Jitendra Babulal Sanghvi | 00271995 | 3 years |
Director | Manjula Devi Shroff | 00297159 | 1 years |
Director | Deval Rajnikant Shah
Shareholder
|
00332722 | 5 years |
Kmp | Deval Rajnikant Shah | <HIDDEN> | 1 years |
Director | Ashokbhai Vijaysinh Barot
Shareholder
|
01192300 | 7 years |
Director | Udayan Dileep Choksi | 02222020 | 1 years |
Director | Kalpit Rajesh Gandhi | 02843308 | 1 years |
Managing Director | Swapnil Jatinbhai Shah
Shareholder
|
05259821 | 4 years |
Director | Arpit Deepakkumar Shah | 07214641 | 2 years |
Director | Chetan Bipinchandra Shah | 10381971 | 2 years |
Director | Hemanshu Nitinchandra Pandya | 10383995 | 2 years |
Director | Naresh Bansilal Shah | 10384306 | 1 years |
Kmp | Nidhi Dilipbhai Kapadia | <HIDDEN> | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 3
Total Amount : 147.7 cr
ICICI Bank Limited
No. of Loans: 2
Total Amount : 48.5 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
RATNATRIS PHARMACEUTICALS PRIVATE LIMITED | Gujarat | 2005 | ₹ 3.7 Cr |
Havix Group Inc | United States | - | - |
Senores Pharmaceuticals INC | United States | - | - |
Read more
The incorporation date of SENORES PHARMACEUTICALS LIMITED is 26 December, 2017
The authorized share capital of SENORES PHARMACEUTICALS LIMITED is INR ₹ 59.0 Cr.
The paid-up capital of SENORES PHARMACEUTICALS LIMITED is INR ₹ 33.3 Cr.
The registered address of SENORES PHARMACEUTICALS LIMITED is 1101 to 1103, 11th floor, South Tower, ONE 42 Opp. Jayanti lal Park, Ambali Bopal Road, NA Ahmedabad Ahmedabad Gujarat - 380054
The CIN number of SENORES PHARMACEUTICALS LIMITED is U24290GJ2017PLC100263.